Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in TMCI held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 6.4M | $8.5M | 0.0% | 9.810% | 0.25% |
| 2 | GAGNON SECURITIES LLC | 5.2M | $7.0M | +67.2% | 8.019% | 1.61% |
| 3 | BlackRock, Inc. | 3.3M | $4.5M | -2.1% | 5.149% | 0.00% |
| 4 | BANK OF AMERICA CORP /DE/ | 3.2M | $4.3M | +38.9% | 4.955% | 0.00% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | $2.0M | β | 2.253% | 0.00% |
| 6 | STATE STREET CORP | 1.2M | $1.7M | +24.3% | 1.904% | 0.00% |
| 7 | CIBC Bancorp USA Inc. | 1.2M | $1.6M | β | 1.878% | 0.00% |
| 8 | MILLENNIUM MANAGEMENT LLC | 1.1M | $1.5M | -23.6% | 1.770% | 0.00% |
| 9 | AQR CAPITAL MANAGEMENT LLC | 1.1M | $1.4M | β | 1.637% | 0.00% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.0M | $1.4M | -11.7% | 1.558% | 0.00% |
| 11 | D. E. Shaw & Co., Inc. | 841K | $1.1M | +33.5% | 1.297% | 0.00% |
| 12 | CITADEL ADVISORS LLC | 826K | $1.1M | +169.9% | 1.273% | 0.00% |
| 13 | WEBER CAPITAL MANAGEMENT LLC /ADV | 590K | $790K | 0.0% | 0.909% | 0.79% |
| 14 | UBS Group AG | 543K | $727K | +84.7% | 0.837% | 0.00% |
| 15 | RENAISSANCE TECHNOLOGIES LLC | 523K | $701K | β | 0.806% | 0.00% |
| 16 | VANGUARD PORTFOLIO MANAGEMENT LLC | 436K | $584K | β | 0.672% | 0.00% |
| 17 | NORTHERN TRUST CORP | 406K | $544K | +3.1% | 0.626% | 0.00% |
| 18 | GOLDMAN SACHS GROUP INC | 388K | $519K | +105.3% | 0.598% | 0.00% |
| 19 | RAYMOND JAMES FINANCIAL INC | 358K | $479K | +10.7% | 0.551% | 0.00% |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 329K | $441K | -6.7% | 0.507% | 0.00% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 318K | $426K | β | 0.490% | 0.00% |
| 22 | XTX Topco Ltd | 286K | $383K | +289.1% | 0.441% | 0.01% |
| 23 | MARSHALL WACE, LLP | 265K | $355K | β | 0.408% | 0.00% |
| 24 | JACOBS LEVY EQUITY MANAGEMENT, INC | 264K | $353K | β | 0.407% | 0.00% |
| 25 | DEUTSCHE BANK AG\ | 251K | $336K | 0.0% | 0.387% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in TMCI β a direct measure of their conviction.
Filings activity in TMCI during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 115 | +0.0% | 17.65% | 14.92 pp | $46M | 46% |
| Q4 2025 | 115 | 0.9% | 32.57% | 111.49 pp | $86M | 77% |
| Q3 2025 | 116 | 6.5% | 144.06% | +59.26 pp | $379M | +70% |
| Q2 2025 | 124 | 9.5% | 84.80% | 32.67 pp | $223M | 28% |
| Q1 2025 | 137 | +3.0% | 117.47% | +14.08 pp | $309M | +14% |
| Q4 2024 | 133 | +1.5% | 103.39% | +17.11 pp | $272M | +20% |
| Q3 2024 | 131 | +5.6% | 86.28% | 11.32 pp | $227M | 12% |
| Q2 2024 | 124 | β | 97.60% | β | $257M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Latest Form 4 transactions by company officers and directors. Insider buys are widely viewed as the highest-conviction signal because executives are risking personal capital.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Treace John T. | Buy | 50K | $3.56 | $178K |
Quick answers to the most common questions about buying TMCI stock.
Based on Q1 2026 13F filings, institutional ownership of Treace Medical Concepts, Inc. stands at 17.6%, held across 115 reporting institutions.
ARMISTICE CAPITAL, LLC is the largest reported institutional holder of TMCI, with approximately 6,364,000 shares worth $0.01B as of Q1 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of TMCI, including MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for TMCI is 51 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
32 institutions opened new positions in TMCI during Q1 2026, while 32 fully exited. 13 added to existing positions and 68 trimmed.
TMCI institutional ownership fell by 14.92 percentage points quarter-over-quarter, with a net change of +0 holders.
The top 10 institutions account for 72.8% of all reported 13F value in TMCI, and the top 25 account for 91.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Treace Medical Concepts, Inc. (TMCI) Institutional Ownership